Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Anticancer Research|February 11, 2015
Correlation between CA125 levels after sixth cycle of chemotherapy and clinical outcome in advanced ovarian carcinomaAngiolo Gadducci, Alice Menichetti, Ilaria Guiggi, et al.
Case Reports in Oncological Medicine|August 4, 2018
Gastric Linitis Plastica and Peritoneal Carcinomatosis as First Manifestations of Occult Breast Carcinoma: A Case Report and Literature ReviewMara Mantiero, Giovanni Faggioni, Alice Menichetti, et al.
Annals of Palliative Medicine|July 24, 2022
Induction chemotherapy with carboplatin and paclitaxel for thymoma in acute respiratory distress due to myasthenia gravis: a case reportGiovanni Maria Comacchio, Beatrice Benetti, Elisabetta Di Liso, et al.
Frontiers in Oncology|March 29, 2021
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA AnalysisLoredana Urso, Grazia Vernaci, Jessica Carlet, et al.
The Oncologist|April 21, 2026
Long-term outcome of isolated locoregional (ILRR) breast cancer (BC) recurrence: a large retrospective Mono-institutional studyGrazia Vernaci, Gaia Griguolo, Fabio Girardi, et al.
Journal of Palliative Medicine|March 20, 2019
Neoplastic Pericardial Effusion: A Monocentric Retrospective StudyElisabetta Di Liso, Alice Menichetti, Maria Vittoria Dieci, et al.
The Oncologist|July 4, 2020
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast CancerFederica Miglietta, Maria Vittoria Dieci, Vassilena Tsvetkova, et al.
The Breast Journal|December 15, 2019
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective studyTommaso Giarratano, Simona Frezzini, Monica Zanocco, et al.
Frontiers in Oncology|June 28, 2019
Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III DiseaseMaria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo, et al.
Therapeutic Advances in Medical Oncology|December 22, 2023
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitorsEmma Zattarin, Luigi Mariani, Alice Menichetti, et al.
Pageof 2